Why Is Trijardy XR So Hard to Find? [Explained for 2026]

If you have ever called multiple pharmacies only to hear "sorry, we don't have that in stock," you are not alone. Trijardy XR — the triple-combination diabetes tablet containing empagliflozin, linagliptin, and metformin — is one of those brand-name medications that can be genuinely difficult to track down at your local pharmacy. In this article, we break down exactly why that happens and what you can do about it.

What Is Trijardy XR and Why Is It Prescribed?

Trijardy XR is a once-daily extended-release tablet that combines three diabetes medications into one: empagliflozin (an SGLT2 inhibitor), linagliptin (a DPP-4 inhibitor), and metformin (a biguanide). It was FDA-approved in 2020 and is manufactured by Boehringer Ingelheim.

Doctors prescribe Trijardy XR when a patient with type 2 diabetes needs more than one medication to control their blood sugar — and they want to simplify the regimen into a single daily pill. Because it contains empagliflozin (the same active ingredient found in Jardiance), it also carries the added benefit of reducing cardiovascular death risk in patients with established heart disease.

Why Can Trijardy XR Be Hard to Find at Pharmacies?

There are several reasons why Trijardy XR may not be sitting on the shelf when you need it:

1. It Contains Empagliflozin — a High-Demand Component

Empagliflozin (also sold as standalone Jardiance) has seen dramatically increased demand in recent years. The FDA has approved empagliflozin for additional conditions — including heart failure with reduced ejection fraction and, as of late 2025, chronic kidney disease. Each new indication has brought millions more patients to this drug class. Because Trijardy XR contains empagliflozin, supply chain pressures affecting Jardiance can ripple into Trijardy XR availability as well.

2. No Generic Is Available Yet

As of 2026, Trijardy XR is a brand-name drug with no FDA-approved generic equivalent in the fixed-dose combination form. This means only one manufacturer — Boehringer Ingelheim — produces it. A single-source supply chain creates vulnerability: if there is a production hiccup, distribution delay, or unusually high demand spike, pharmacies cannot simply source a generic substitute to fill the gap.

3. It Comes in Multiple Strengths — Not Every Pharmacy Stocks All of Them

Trijardy XR comes in four different strength combinations: 5mg/2.5mg/1000mg, 10mg/5mg/1000mg, 12.5mg/2.5mg/1000mg, and 25mg/5mg/1000mg. A pharmacy may stock one or two of these but not all four. If your prescription is for a less-common strength, you may need to look beyond your usual pharmacy to find it.

4. Insurance and Prior Authorization Delays

Even if your pharmacy has Trijardy XR in stock, your insurance plan may require prior authorization or step therapy before covering it. Step therapy means you may need to try (and document failure on) other diabetes medications first. This process can delay your ability to fill the prescription by days or even weeks, which patients often experience as the medication being "unavailable."

5. Small Pharmacies Often Don't Keep It in Regular Inventory

Brand-name combination diabetes medications like Trijardy XR have a high sticker price (retail cash price is often $350–$750 per month). Smaller independent pharmacies may not keep it as standing inventory due to the carrying cost. They will typically order it for you within 1-2 business days, but if you need it urgently, this creates a gap.

How to Tell If This Is a Shortage vs. a Stocking Issue

A true FDA drug shortage means the manufacturer cannot produce enough supply to meet national demand. As of 2026, Trijardy XR is NOT listed on the FDA Drug Shortage database as an active shortage. What you are more likely experiencing is a localized stocking issue — meaning your specific pharmacy or regional distribution network simply doesn't have it in inventory right now, even though the drug exists and is being manufactured.

The difference matters because the solution is different. A real shortage requires your doctor to consider alternative medications. A stocking issue just requires finding a pharmacy that has it.

What Can You Do When You Can't Find Trijardy XR?

Here are the most effective steps to take when Trijardy XR isn't available at your usual pharmacy:

• Use medfinder to find which pharmacies near you have it in stock — without spending an hour on hold
• Call independent pharmacies — they often have access to multiple wholesalers and can source medications faster than large chains
• Ask your pharmacy to order it — most pharmacies can receive special orders within 1-2 business days
• Consider mail-order pharmacy for 90-day supplies — less susceptible to local stock-outs
• Talk to your doctor about alternatives to Trijardy XR if the stocking issue is ongoing

The Bottom Line

Trijardy XR can be hard to find not because it's in a national shortage, but because it's a brand-name-only drug with high-demand components, multiple strengths, and variable pharmacy stocking practices. The good news is that with the right tools and a bit of persistence, most patients are able to locate it. Start by checking availability at multiple pharmacies in your area — and don't assume the first "no" means it's unavailable everywhere.

For step-by-step guidance on finding Trijardy XR in stock, read our guide on how to find Trijardy XR near you in 2026.